In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity (2011)
- Authors:
- USP affiliated authors: CARVALHO, IVONE - FCFRP ; SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.4155/fmc.11.67
- Assunto: DOENÇA DE ALZHEIMER (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 3, n. 8, p. 947-960, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Vinícius Barreto da et al. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity. Future Medicinal Chemistry, v. 3, n. 8, p. 947-960, 2011Tradução . . Disponível em: https://doi.org/10.4155/fmc.11.67. Acesso em: 07 nov. 2024. -
APA
Silva, V. B. da, Andrade, P. de, Kawano, D. F., Morais, P. A. B., Almeida, J. R. de, Carvalho, I., et al. (2011). In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity. Future Medicinal Chemistry, 3( 8), 947-960. doi:10.4155/fmc.11.67 -
NLM
Silva VB da, Andrade P de, Kawano DF, Morais PAB, Almeida JR de, Carvalho I, Taft CA, Silva CHT de P da. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity [Internet]. Future Medicinal Chemistry. 2011 ; 3( 8): 947-960.[citado 2024 nov. 07 ] Available from: https://doi.org/10.4155/fmc.11.67 -
Vancouver
Silva VB da, Andrade P de, Kawano DF, Morais PAB, Almeida JR de, Carvalho I, Taft CA, Silva CHT de P da. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity [Internet]. Future Medicinal Chemistry. 2011 ; 3( 8): 947-960.[citado 2024 nov. 07 ] Available from: https://doi.org/10.4155/fmc.11.67 - Combinatorial chemistry underpinning drug discovery and development
- Novel aryl 'beta'-aminocarbonyl derivates as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures
- Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
- Using computer-aided drug design and medicinal chemistry strategies in the fight against diabetes
- Disaccharide glycosides and glycopeptides as potential acceptor substrates for Trypanosoma cruzi trans-sialidase
- Molecular dynamics, density functional, ADMET predictions, virtual screening, and molecular interaction field studies for identification and evaluation of novel potential CDK2 inhibitors in cancer therapy
- Cyclooligomerisation of azido-alkyne-functionalised sugars: synthesis of 1,6-linked cyclic pseudo-galactooligosaccharides and assessment of their sialylation by Trypanosoma cruzi trans-sialidase
- RNA interference in drug discovery
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
Informações sobre o DOI: 10.4155/fmc.11.67 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
